Skip to main content
High RiskFDAfda-F-1254-2020UNDECLARED ALLERGEN

Gluten-Free Organic Mesa Sunrise Cereal USA, Nature's Path brand. Shop Order # 127895. Product is Ready to eat breakfast cereal and shel...

Units Affected
384
Recall Date
August 7, 2020
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1254-2020.

Undeclared Wheat and/or Barley.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1254-2020.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Natures Path Foods Usa, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1254-2020.

Natures Path Foods USA, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Natures Path Foods Usa, Inc. Recall FAQ

Natures Path Foods Usa, Inc. is the subject of a bakery & grains safety report: Gluten-Free Organic Mesa Sunrise Cereal USA, Nature's Path brand. Shop Order # 127895. Product is Ready to eat breakfast cereal and shel.... The notice was published on August 7, 2020 by the U.S. Food and Drug Administration (FDA). Approximately 384 units are potentially affected.